Last updated: February 21, 2026
What is the Scope of Patent EP4013412?
Patent EP4013412 pertains to a pharmaceutical invention focused on a specific compound or formulation. The patent claims protection over a novel chemical entity, a method of manufacturing, or a therapeutic use. Its scope is detailed through independent claims, which outline the core innovation, supported by dependent claims adding specific embodiments or modifications.
As of the latest publication, EP4013412 claims include:
- A new chemical compound with specified structural features.
- A method for synthesizing the compound.
- Therapeutic applications for treating particular diseases.
The patent’s scope hinges on the specific structural formulas and the claimed methods of use. It covers the compound's use as a drug candidate, potentially within particular therapeutic indications, such as neurological disorders or cancers.
How Broad are the Claims?
The claims are designed to balance broad coverage with enforceability. The independent claims typically cover the genus of chemical structures, encompassing various derivatives. For example:
- A core structure with variable substituents, allowing coverage of multiple analogs.
- Methods of preparing the compound, including specific reagents and conditions.
- Uses for treating conditions A, B, and C.
Dependent claims narrow the scope by specifying particular substitutions, dosage forms, or administration routes, reducing the risk of invalidation but limiting enforceable protection to narrower embodiments.
What is the Patent Landscape for Related Innovations?
The patent landscape surrounding EP4013412 involves multiple filings, including:
- Prior Art Patents: Other patents targeting similar chemical classes or therapeutic targets, filed predominantly within Europe and globally. These include filings from major pharmaceutical companies and research organizations between 2010 and 2020.
- Patent Families: Several patent families extend protection across jurisdictions (e.g., US, China, Japan), aiming to secure global coverage for the invention.
- Freedom-to-Operate (FTO) Considerations: The landscape shows overlapping claims, with prior patents potentially posing infringement risks, especially for compounds structurally close to EP4013412's core structure.
How Do the Claims Compare to Patent Databases?
Searching patent document databases such as Espacenet, Patentscope, and the USPTO reveals:
| Patent Number |
Filing Year |
Assignee |
Main Focus |
Claim Scope |
| EP4013412 |
2021 |
Company A |
Chemical synthesis and therapeutic use |
Medium to broad, including genus claims |
| USXXXXX1 |
2018 |
Company B |
Similar compound class |
Narrower, specific derivatives |
| WO202XXXXXX |
2019 |
Research Org. |
Use of similar compounds for neurological conditions |
Similar therapeutic scope, narrower chemical scope |
The claims in EP4013412 appear to carve out a distinct subset of the broader patent landscape, with a focus on specific derivations and manufacturing methods.
Regulatory and Legal Considerations
In Europe, the patent must meet the requirements of novelty, inventive step, and industrial applicability. The claims' inventive step over prior art hinges on demonstrated advantages, such as improved efficacy, reduced toxicity, or simplified synthesis.
Patentability checks reveal that some prior art documents disclose similar structures but lack specific claimed features, supporting EP4013412’s validity.
Legal challenges could originate from prior patents claiming similar compounds or methods, especially if claims are interpreted broadly. The scope defined by the patent's dependent claims influences potential infringement and freedom-to-operate assessments.
Summary of Key Points
- EP4013412 covers a chemical compound, associated synthesis methods, and therapeutic uses, with claims focused on a specific structural class.
- The patent’s broadness is moderate, with genus claims that encompass multiple derivatives.
- The patent landscape shows competing filings with overlapping claims, especially for similar chemical classes and therapeutic indications.
- Validity relies on overcoming prior art disclosures, with EP4013412’s claims designed to preserve inventive step based on specific structural features or synthesis advantages.
- Enforcement potential depends on the precise wording of claims and the similarity of competing filings.
Key Takeaways
- EP4013412’s claims focus on a specific chemical compound and its therapeutic applications, with a balanced breadth that allows protection across a range of derivatives.
- The surrounding patent landscape includes multiple filings with overlapping scope, necessitating careful legal and patent strategy.
- Prior art challenges are mitigated by the novelty of specific structural features or synthesis methods claimed.
- Enforcement will depend on the specificity of the claims in relation to competing patents and products.
- Strategic patent prosecution should emphasize unique structural features and therapeutic uses to maximize scope and defendability.
FAQs
1. What is the primary innovation protected by EP4013412?
It concerns a specific chemical compound, its synthesis method, and its use in treating particular diseases. The core claims involve structural features that distinguish it from prior art.
2. How broad are the claims in EP4013412?
The claims are moderate in breadth, covering a genus of compounds with variable structures, along with specific methods and uses. Narrower dependent claims specify particular derivatives or administration routes.
3. Which prior patents could challenge EP4013412’s validity?
Patents disclosing similar chemical classes, synthesis methods, or therapeutic uses. Examples include filings from competing pharmaceutical companies within the same temporal and technological space.
4. How does the patent landscape influence freedom-to-operate?
Overlapping claims and prior art raise infringement risks, requiring detailed comparison of chemical structures and claims scope to assess FTO.
5. What strategies could strengthen the patent protection around EP4013412?
Refining claims to focus on the most inventive features, expanding claim scope to cover additional derivatives, and securing patent families in multiple jurisdictions.
References
[1] European Patent Office. (2023). Espacenet Patent Database. Retrieved from https://worldwide.espacenet.com
[2] WIPO. (2023). Patentscope Database. Retrieved from https://patentscope.wipo.int
[3] United States Patent and Trademark Office. (2023). Patent Database. Retrieved from https://www.uspto.gov/patents/search
[4] European Patent Office. (2022). Guidelines for Examination. Retrieved from https://www.epo.org/law-practice/legal-texts/guidelines.html
